A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients
2013 ◽
Vol 14
(3)
◽
pp. 259-267
◽
2019 ◽
Vol 37
(6)
◽
pp. 1294-1300
◽
2013 ◽
Vol 11
(3)
◽
pp. 84-84
2016 ◽
Vol 14
(6)
◽
pp. 552-562
◽
2013 ◽
Vol 2
(1)
◽
2017 ◽
Vol 86
(4)
◽
pp. 254-256
◽